Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Will MR-linac Prove A Turning Point For Radiotherapy And For Elekta?

This article was originally published in Clinica

Executive Summary

Elekta last year set off on what it hoped was a path to recovery, after reporting significantly below-par results for fiscal 2015 under the watch of the then-CEO Niklas Savander. The Swedish cancer treatment specialist unveiled a comprehensive action program and underwent a major executive reshuffle, including the appointment of a new head, Richard Hausmann, formerly chief of GE Healthcare’s MR business.